Europe DNA Diagnostics Market (2016-2022)

Europe DNA Diagnostics Market (2016-2022)

  • January 2017 •
  • 101 pages •
  • Report ID: 4700273 •
  • Format: PDF
DNA diagnostic methods are incorporated by several end users such as central laboratories, point of care testing and self-testing. Laboratories have grown in importance over the years, as the prevalence of disease and the need for laboratory testing have significantly grown in the last decade. Therefore, the growing importance of laboratories has contributed to the growth of the Europe DNA diagnostic market.

Software such as qPCR analysis software, Gene Mapping software, gene expression and pathway analysis software, data interpretation & storage software and drawing, analysis & visualization of pathways software are frequently used in the Europe DNA diagnostics market, The use of such software programs has significantly reduced the complexities in diagnostics produces and as a result significantly reducing the time needed to perform complex tasks. The increase in modification of various products & techniques such as PCR, Microarray and In situ hybridization has made the diagnostic processes relatively easier over traditional techniques.

The report highlights the adoption of DNA Diagnostics in Europe. Based on the Product Types, the Europe DNA Diagnostics Market is segmented into Instruments, Reagents and Service & software segment. Based on the Application, the market is bifurcated into Oncology, Infectious disease testing, Myogenic disorder diagnosis, Clinical confirmation diagnostics, Prenatal diagnosis, Pre-implantation diagnostics and other segments. Based on the Technology, the market is bifurcated into PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry and other segments. Further, the market is segmented into POC (Point-of-Care), Central Laboratories and Self-Testing segments based on the End Users. The countries included in the report are Germany, UK, France, Russia, Spain, Italy and Rest of Europe.

Key Players profiled in the report includes:
Sysmex Corporation, Bayer Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid Inc, Hologic Corporation, Illumina, Novartis International Ag, Thermo Fisher Scientific Inc. and Bio-Rad Laboratories.